Bridgewest

02.28.2019

Bridgewest Group Acquires New Zealand-Based Provoke Solutions

01.27.2019

BioDuro partners with Advent International

11.30.2018

Endura Technologies And UNISOC Announce Commercial Partnership

10.09.2018

BioDuro Launches New Drug Discovery Site in San Diego, CA

03.19.2018

BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent

03.05.2018

BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities

01.30.2018

BioDuro announces cooperation agreement with Porton Pharma Solutions

12.05.2017

Endura Technologies Announces Availability of ET7730 - Industry's Smallest 6A Embedded Voltage Regulator (eVR™) Solution in 1mm(3) Volume, Operating at 130MHz

03.29.2017

BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify™

11.15.2016

Ubiqomm and Skyriver team together for "Wi-Fi in the Sky" BVLOS drone flights

11.08.2016

BioDuro, LLC Increases Spray Dried Drug Product Manufacturing Capacity

09.17.2016

BioDuro completes infrastructure expansion in Shanghai to accommodate 130 additional chemistry and biology staff for its integrated drug discovery and development programs and to enable rapid scale up for process-chemistry

05.04.2016

Endura Technologies and MediaTek Inc. Announce Commercial Partnership

03.22.2016

Molecular Response Expands Its Biospecimen Storage Capacity to Provide Biorepository Services

01.07.2016

BioDuro, LLC Adds Industry Veteran CFO To Executive Team

11.11.2015

BioDuro, LLC Announces Merger with Formex, LLC, and New Leadership

09.15.2015

Molecular Response Appoints the Former Head of Translational Medicine Oncology at MedImmune/AstraZeneca, Brett Hall, Ph.D., as Chief Executive Officer

08.03.2015

Formex Acquires Gerteis MINI-PACTOR™ and Korsch XL 100™

05.15.2015

Biotech Investment Group Announced Today the Promotion of Cyrus K. Mirsaidi to the Board of Directors of Molecular Response as Vice Chairman, and His New Appointment as President and CEO of Formex

05.15.2015

Molecular Response Announces Sale of Business Unit to Crown Bioscience

05.15.2015

Barbara Holland Joins Formex as Director of Business Development for the South East Region

05.15.2015

BioAtla Partners With BioDuro To Advance Two Proprietary Antibody Therapeutics In China

05.15.2015

ProHomes.com launch gives landlords affordable access to tools that boost organization, efficiency and profitability

05.15.2015

BioAtla Receives Broad Patent For Antibody Development

05.15.2015

Boston Strategics Corporation Announces Key Agreement in Translational Oncology with Molecular Response

05.15.2015

Formex Expands Services With Additional Scientific Staff And Equipment

05.15.2015

Molecular Response Announces the Opening of New Facilities in San Diego, Accredited by The College of American Pathologists

05.15.2015

Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control

05.15.2015

John McCarty Joins Formex, LLC As Scientific Advisor

05.15.2015

Steve Massah Appointed President & CEO AT Formex, LLC

05.15.2015

Formex CSO Blair West to Speak at 3rd Drug Formulation & Bioavailability Conference

05.15.2015

Formex Announces Validation And Launch Of Dedicated Cytotoxic And Potent Handling cGMP Suites At AAPS

05.15.2015

Formex Announces AAPS Annual Meeting Mobile App Sponsorship

05.15.2015

Yvonne Vergurgt Appointed Sr. Director Business Development At Formex, LLC

05.15.2015

News

Bridgewest Group Acquires New Zealand-Based Provoke Solutions

BioDuro partners with Advent International

Endura Technologies And UNISOC Announce Commercial Partnership

BioDuro Launches New Drug Discovery Site in San Diego, CA

BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent

BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities

BioDuro announces cooperation agreement with Porton Pharma Solutions

Endura Technologies Announces Availability of ET7730 - Industry's Smallest 6A Embedded Voltage Regulator (eVR™) Solution in 1mm(3) Volume, Operating at 130MHz

BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify™

Ubiqomm and Skyriver team together for "Wi-Fi in the Sky" BVLOS drone flights

BioDuro, LLC Increases Spray Dried Drug Product Manufacturing Capacity

BioDuro completes infrastructure expansion in Shanghai to accommodate 130 additional chemistry and biology staff for its integrated drug discovery and development programs and to enable rapid scale up for process-chemistry

Endura Technologies and MediaTek Inc. Announce Commercial Partnership

Molecular Response Expands Its Biospecimen Storage Capacity to Provide Biorepository Services

BioDuro, LLC Adds Industry Veteran CFO To Executive Team

BioDuro, LLC Announces Merger with Formex, LLC, and New Leadership

Molecular Response Appoints the Former Head of Translational Medicine Oncology at MedImmune/AstraZeneca, Brett Hall, Ph.D., as Chief Executive Officer

Formex Acquires Gerteis MINI-PACTOR™ and Korsch XL 100™

Biotech Investment Group Announced Today the Promotion of Cyrus K. Mirsaidi to the Board of Directors of Molecular Response as Vice Chairman, and His New Appointment as President and CEO of Formex

Molecular Response Announces Sale of Business Unit to Crown Bioscience

Barbara Holland Joins Formex as Director of Business Development for the South East Region

BioAtla Partners With BioDuro To Advance Two Proprietary Antibody Therapeutics In China

ProHomes.com launch gives landlords affordable access to tools that boost organization, efficiency and profitability

BioAtla Receives Broad Patent For Antibody Development

Boston Strategics Corporation Announces Key Agreement in Translational Oncology with Molecular Response

Formex Expands Services With Additional Scientific Staff And Equipment

Molecular Response Announces the Opening of New Facilities in San Diego, Accredited by The College of American Pathologists

Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control

John McCarty Joins Formex, LLC As Scientific Advisor

Steve Massah Appointed President & CEO AT Formex, LLC

Formex CSO Blair West to Speak at 3rd Drug Formulation & Bioavailability Conference

Formex Announces Validation And Launch Of Dedicated Cytotoxic And Potent Handling cGMP Suites At AAPS

Formex Announces AAPS Annual Meeting Mobile App Sponsorship

Yvonne Vergurgt Appointed Sr. Director Business Development At Formex, LLC

Biotech Investment Group Launches Formex, LLC